Avantor Inc (AVTR)
22.55
+0.24
(+1.08%)
USD |
NYSE |
Nov 04, 16:00
22.00
-0.55
(-2.44%)
Pre-Market: 09:00
Avantor Revenue (Quarterly): 1.714B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.714B |
June 30, 2024 | 1.703B |
March 31, 2024 | 1.680B |
December 31, 2023 | 1.723B |
September 30, 2023 | 1.720B |
June 30, 2023 | 1.744B |
March 31, 2023 | 1.780B |
December 31, 2022 | 1.795B |
September 30, 2022 | 1.856B |
June 30, 2022 | 1.910B |
March 31, 2022 | 1.950B |
December 31, 2021 | 1.908B |
September 30, 2021 | 1.834B |
June 30, 2021 | 1.859B |
Date | Value |
---|---|
March 31, 2021 | 1.786B |
December 31, 2020 | 1.791B |
September 30, 2020 | 1.605B |
June 30, 2020 | 1.479B |
March 31, 2020 | 1.519B |
December 31, 2019 | 1.524B |
September 30, 2019 | 1.504B |
June 30, 2019 | 1.532B |
March 31, 2019 | 1.480B |
December 31, 2018 | 1.474B |
September 30, 2018 | 1.494B |
June 30, 2018 | 1.478B |
March 31, 2018 | 1.418B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.479B
Minimum
Jun 2020
1.950B
Maximum
Mar 2022
1.744B
Average
1.762B
Median
Revenue (Quarterly) Benchmarks
Revvity Inc | 691.68M |
Bruker Corp | 800.70M |
Azenta Inc | 172.81M |
Harvard Bioscience Inc | 23.10M |
Bionano Genomics Inc | 7.771M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 57.80M |
Total Expenses (Quarterly) | 1.590B |
EPS Diluted (Quarterly) | 0.08 |
Enterprise Value | 19.98B |
Gross Profit Margin (Quarterly) | 32.92% |
Profit Margin (Quarterly) | 3.37% |
Earnings Yield | 2.00% |
Operating Earnings Yield | 4.10% |
Normalized Earnings Yield | 2.020 |